Benzamide, 3-[(1S)-2-methoxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-(3-methyl-1,2,4-thiadiazol-5-yl)- manufacturers
- GKA-71
-
- $1980.00
-
2026-05-11
- CAS:863504-35-2
- Purity:
- Supply Ability: 10g
|
| | Benzamide, 3-[(1S)-2-methoxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-(3-methyl-1,2,4-thiadiazol-5-yl)- Basic information |
| | Benzamide, 3-[(1S)-2-methoxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-(3-methyl-1,2,4-thiadiazol-5-yl)- Chemical Properties |
| density | 1.352±0.06 g/cm3(Predicted) | | pka | 10.43±0.70(Predicted) |
| | Benzamide, 3-[(1S)-2-methoxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-(3-methyl-1,2,4-thiadiazol-5-yl)- Usage And Synthesis |
| Description | GKA-71 is a potent glucokinase activator (GKA). | | Uses | GKA-71 is an orally active Glucokinase activator, possesses an islet protective effect[1]. | | References | [1] Maria Srhede Winzell, et al. Chronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed mice. Eur J Pharmacol. 2011 Aug 1;663(1-3):80-6. DOI:10.1016/j.ejphar.2011.05.009 |
| | Benzamide, 3-[(1S)-2-methoxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-(3-methyl-1,2,4-thiadiazol-5-yl)- Preparation Products And Raw materials |
|